Hong Kong is advancing clinical trials for histotripsy, a non-invasive ultrasound treatment for kidney cancer. Three major hospitals are set to begin trials involving 30 patients, aiming to validate the technology's safety and efficacy. This initiative is part of Hong Kong's broader effort to become a hub for developing such advanced medical technologies, supported by local business magnates. AI
RANK_REASON The cluster describes the expansion of clinical trials for a novel medical treatment, which falls under research. [lever_c_demoted from research: ic=1 ai=0.0]
- CUHK Medical Centre
- Gleneagles Hospital Hong Kong
- histotripsy
- Hong Kong
- Hong Kong Sanatorium & Hospital
- Li Ka-shing
- Li Ka Shing Foundation
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →